Pay in 4 interest-free payments of $148.00 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
1186/s13036-019-0188-x
Development of Prodrug–Payloads for Targeted Therapeutic Applications of Platinum–Acridine Anticancer Agents
1039/C9CC02655J
Synthesis of Bispecific Antibodies using Genetically Encoded Unnatural Amino Acids
Macrocyclic Dual-Locked “Turn-On” Drug for Selective and Traceless Release in Cancer Cells
DBM-PEG2-BCN Quantity:250 mg 1186/s13036-019-0188-xReferences: 1) Hull, E. A.; et al. Homogeneous Bispecifics by Disulfide Bridging. Bioconjugate Chem. 2014, 25(8), 1395 1401. DOI: 10. 1021 bc5002467 Keywords: Bispecific Antibodies; Disulfide Bridging; Homogeneous Bispecifics; Dibromomaleimide